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ABSTRACT

Introduction Women comprise two-thirds of people with
dementia, making female sex a significant dementia risk
factor. Both type 1 diabetes (T1D) and type 2 diabetes
(T2D) are known dementia risk factors with an increasing
global incidence. Understanding whether subtle sex
differences persist in cognitive function prior to dementia
in the context of diabetes may help elucidate the
magnitude of sex effects on dementia risk.
Research design and methods We examined cross-
sectional data from the Study of Longevity in Diabetes
(SOLID), a prospective cohort study of members of
Kaiser Permanente Northern California aged 60 years
and older with T1D (n=758), T2D (n=232) and without
either T1D or T2D (n=247). We used factor analysis to
generate summary scores of cognitive domains and used
regression analyses to examine the associations between
sex and cognition adjusting for sociodemographic and
cardiovascular confounders.
Results We included 1237 participants (630 women
and 607 men) with mean age 68 years. By design,
the distribution of men and women in T1D, T2D and
no diabetes was similar. Women had better cognitive
performance than men in global cognition (β=0.21,
95% CI 0.16 to 0.26), language (β=0.08, 95% CI 0.004 to
0.15), executive function (β=0.13, 95% CI 0.05 to 0.20),
episodic verbal memory (β=0.68, 95% CI 0.59 to 0.77) and
attention (β=0.20, 95% CI 0.11 to 0.28) but not in episodic
visual memory (β=0.006, 95% CI −0.07 to 0.09) adjusting
for age and education independent of diabetes status. We
did not find an interaction between sex and diabetes status
for any of the cognitive outcomes.
Conclusions Women in late mid-life have better cognitive
performance than men in many cognitive domains
independent of the presence of T1D or T2D. Further work
is required to understand whether these differences
change over time or in older cohorts and to understand
their relationship to subsequent dementia.

INTRODUCTION
Female sex is a risk factor for dementia.1
Women make up approximately half the
world population,2 yet two-thirds of people
with dementia are women. This makes the
disproportionate burden of dementia in
women a large public health concern. The
reasons for this increased risk in women are

Significance of this study
What is already known about this subject?
►► Both female sex and diabetes are risk factors for de-

mentia, but the underlying mechanisms are unclear.
►► It is not known whether the previously described sex

differences in cognitive function differ depending on
whether a person has type 1, type 2 or no diabetes.

What are the new findings?
►► In a study of 1237 people (mean age 68 years), we

found that women had better cognitive performance
than men in a number of cognitive domains including global cognition, language, executive function,
attention and verbal memory.
►► Women and men had similar visual memory scores.
►► The sex differences in cognition did not vary by the
presence or absence of diabetes or whether a person had type 1 or type 2 diabetes.

How might these results change the focus of
research or clinical practice?
►► Our results demonstrate the presence of sex dif-

ferences in cognition across diabetes states and
encourage further research to better understand
whether the differences we report change over time
and their relationship to subsequent dementia.

unclear but previous work suggest that there
may be sex-specific etiological factors in addition to simply increased longevity.3 The global
incidence of both type 1 diabetes (T1D) and
type 2 diabetes (T2D) is increasing4 and,
depending on the population studied, there
also appears to be sex differences in diabetes
incidence.5 Recently, both T1D and T2D have
been shown to be associated with an increased
risk of dementia.6 7 However, whether the
known sex differences in dementia risk
extend to those with diabetes or is altered
by diabetes is poorly understood.8 There are
sex-
related differences in the incidence of
diabetes complications,9–11 yet, it is unknown
whether there are also sex differences in
cognitive function related to diabetes.

BMJ Open Diab Res Care 2021;9:e001646. doi:10.1136/bmjdrc-2020-001646
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Sex, diabetes status and cognition:
findings from the study of longevity
in diabetes

Epidemiology/Health services research

RESEARCH DESIGN AND METHODS
Study population
The Study of Longevity in Diabetes (SOLID) is a prospective cohort study of aging and diabetes that recruited
members of Kaiser Permanente Northern California
(KPNC) aged 60 years and older with T1D, T2D and
without either T1D or T2D. Details of participant eligibility and inclusion have been published previously and
briefly presented in online supplemental figure 1.16–18
Potential participants with T1D were identified in electronic medical records using International Classification
of Diseases (ICD)-9 and ICD-10 codes for T1D (250.x1,
250.x3 or E10.x) or T2D (250.x0, 250.x2, E11.x). As per
previous work using the SOLID dataset,16–18 individuals
with diagnostic codes related to both types of diabetes
were classified as having T1D if at least 75% of diagnostic codes related to diabetes were for T1D specifically
and the member was prescribed insulin to reduce the
risk of misclassification. Enrolled participants with T1D
were then used to guide recruitment of two comparator
groups: people with T2D and people without either T1D
or T2D. Individuals with T1D were population frequency
matched to potential participants with T2D or without
either T1D or T2D. Individuals with diagnostic codes
related to both types of diabetes were classified as having
T2D if at least 75% of diagnostic codes related to diabetes
were for T2D. Population distribution matching was
performed on the following factors: sex, age (grouped
as: 60–64, 65–69, 70–74, 75–79, 80–84, 85–89, 90+ years),
race/ethnicity and education.
Participants completed a number of items regarding
demographic, general health, diabetes complications,
health literacy (Rapid Estimate of Adult Literacy in
Medicine-Short Form,19 mood (Geriatric Depression
Scale (GDS)) and sleep quality (a modified version of
the Pittsburg Sleep Quality Index (PSQI)).20 Presence of
2

microvascular (retinopathy, neuropathy, nephropathy)
and macrovascular disease (stroke, myocardial infarction) at baseline were captured through self-report of a
physician’s diagnosis at baseline. A comprehensive cognitive battery, described below, was then administered by
trained interviewers.
Cognitive function
We conducted factor analysis on the cognitive assessments of all participants and identified five cognitive domains: language, executive function, episodic
verbal memory, episodic visual memory and simple
attention. The language domain was comprised of the
phonemic fluency test (F and L), the category fluency
test (animals and vegetables), list sorting (two alternative lists) and Multilingual Naming Test. The executive function domain comprised the Trail Making
Test (A and B), the Digit Symbol Substitution Test and
the Stroop Color and Word Tests. The episodic verbal
memory domain consisted of the Word List Learning
Test (immediate and delayed). The episodic visual
memory domain consisted of the Word List Learning
Test (immediate and delayed) and the Benson Complex
Figure Copy (immediate and delayed). The simple
attention domain was composed of the Diamond and
TMX cancellation tests. Each test score was converted
score (mean=0; SD=1). For each domain, a
to a z-
summary score was calculated by summing the z-scores
for individuals who completed at least 50% of the relevant tests. A global cognition score was calculated as the
average of the five domain-specific summary scores for
individuals who competed at least 50% of all cognitive
function tests.
Covariables
Age was calculated from date of baseline interview and
date of birth. Diabetes duration was calculated using
self-
reported age of diabetes onset. Race/ethnicity
(white, Hispanic, Asian, African-American and other),
educational attainment, presence of microvascular
and macrovascular disease (retinopathy, neuropathy, nephropathy, stroke, myocardial infarction) and
diabetes complications (lifetime exposure of severe
hypoglycemia requiring hospital care and lifetime
exposure to diabetic ketoacidosis (DKA)) were based
on self-report. We categorized educational attainment
as: ‘college degree or greater’ or ‘less than a college
degree’.
Analytic sample
Of the 1311 individuals enrolled in SOLID (805 individuals with T1D, 248 individuals with T2D, 258 individuals without diabetes), we excluded 4 participants with
missing information on educational attainment and
70 participants who were missing the global cognition
score, resulting in a final analytic sample of 1237 for
the whole study.
BMJ Open Diab Res Care 2021;9:e001646. doi:10.1136/bmjdrc-2020-001646
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Clarifying whether sex differences persist in cognitive
function in the context of diabetes helps elucidate the
magnitude of sex effects on dementia risk.
Neuropsychological testing in people without dementia
allows the detection of subtle cognitive changes that may
precede the development of dementia. This allows the
potential to identify important mechanisms and risk
factors prior to the development of overt functional
impairment. For example, when compared with men,
women tend to perform more poorly in some cognitive
tasks and better in others.12 13 The reasons underlying
these sex differences are unknown but may be related
to the neuronal activity of sex hormones.13–15 Greater
understanding of the factors associated with increased
dementia risk is essential to the targeting of interventions
to high-risk groups such as women. We evaluated whether
the associations of sex and cognitive function in mid-
later life differs by diabetes status in a group of people
without dementia. Our hypothesis was that women would
perform more poorly in the cognitive tests than men and
these would differ by diabetes status.

Epidemiology/Health services research

RESULTS
Sample characteristics
Of the initial 1311 people recruited into the study, a
total of 1237 participants (630 women and 607 men)
had sufficient data to be included in the current study.
The sample characteristics of those who completed and
did not complete all cognitive tests (n=70) are presented
in online supplemental table 1. Broadly, those who did
not complete all cognitive tests were older, less likely to
hold a college degree, had lower household income,
were diagnosed with diabetes at a younger age, had
longer disease duration and were more likely to report a
history of severe hypoglycemia and DKA than those who
BMJ Open Diab Res Care 2021;9:e001646. doi:10.1136/bmjdrc-2020-001646

completed all cognitive tests. Table 1 describes the characteristics of study participants in the whole group and
stratified by sex.
The mean age of men and women in all groups were
similar (~68 years). Approximately 85% of the sample
were of white ethnicity. Compared with men, women
were less likely to have completed a college or higher
degree (58% vs 64%, p=0.03) and reported lower household income (p<0.0001), lower alcohol use (p=0.04) and
worse sleep quality (mean PSQI=8.5 vs mean PSQI=7.6;
p<0.0001). Women had higher GDS scores than men
(2.2 vs 1.8 p=0.003). By design, the distribution of men
and women was similar in those with T1D, T2D and no
diabetes (~50%). Table 2 describes the characteristics of
study participants stratified by sex and diabetes status.
The mean age of diabetes diagnosis was approximately 28
years in those with T1D and was approximately 55 years
in those with T2D. In those with T1D, men had a little
longer duration of diabetes (40.4 years, SD=13.9) than
women (38.0 years, SD=16.0). A similar pattern was seen
in those with T2D, but this difference was not statistically
significant (men: 14.5 years; women: 13.5 years). Participants with T1D reported higher rates of microvascular
and macrovascular complications, severe hypoglycemia
and DKA than those with T2D or with diabetes. However,
these rates were similar between men and women except
for lifetime exposure to DKA which was more commonly
reported by women (35%) than men (21%) (p<0.0001).
Associations between sex and cognitive outcomes
Table 3 presents the associations between female sex and
the different cognitive domains across the whole group
and stratified by diabetes status.
We used a linear term for age as it resulted in a slightly
better model fit than a quadratic term (AIC 1548.5 vs
1551.3). In the whole group, women had better cognitive performance than men in global cognition (β=0.21,
95% CI 0.16 to 0.26), language (β=0.08, 95% CI 0.004 to
0.15), executive function (β=0.13, 95% CI 0.05 to 0.20),
episodic verbal memory (β=0.68, 95% CI 0.59 to 0.77)
and attention (β=0.20, 95% CI 0.11 to 0.28) (all p<0.01)
but not in episodic visual memory (β=0.006, 95% CI −0.07
to 0.09) adjusting for age and education. The stepwise
inclusion of diabetes status, race/ethnicity, PSQI and
GDS score did not meaningfully change these associations (maximum β change=25%). We did not find a statistically significant sex×diabetes status interaction for any
of the cognitive outcomes in any of the adjusted models.
The inclusion of measures of cardiovascular health and
health literacy resulted in an attenuation of the associations between female sex and the cognitive outcomes
with the previously described association between female
sex and greater performance in language no longer
statistically significant (β=0.05, 95% CI −0.03 to 0.12).
In exploratory sensitivity analysis, we examined the
associations between sex and cognition adjusting for age,
education, race, PSQI and GDS stratified by diabetes
status (table 2). In those with T1D, women had better
3
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Statistical analyses
We examined the distribution of baseline characteristics
in the overall sample, then by sex and by diabetes status.
Within each of the categories of no diabetes, T1D and
T2D, we examined mean standardized scores on global
and domain-specific cognitive measures without covariate
adjustment. For our main analysis, we specified linear
regression models to examine the association between
sex (using men as reference) and performance on global
and domain-
specific measures of cognition. First, we
performed these models in the whole group, including
diabetes status as a covariate. We then specified linear
regression models of the associations between sex and the
cognitive outcomes among individuals with no diabetes,
T1D and T2D separately. Literature research and knowledge of previously published associations found in this
sample guided our identification of covariates. In each of
these models, we initially fitted base models that adjusted
for age and education. We then added diabetes status,
race/ethnicity, PSQI and GDS score in a stepwise fashion
to explore how these factors, that have been shown to
be associated with cognition in this sample,17 18 influenced any sex-cognitive performance relationship. We
then tested a final model including health literacy and
cardiovascular health measures (neuropathy, nephropathy, retinopathy, stroke and myocardial infarction).
We also explored whether the relationship between
age (adjusting for sex and education) and the cognitive
scores was linear or quadratic using an Akaike Information Criterion (AIC) measure of model fit.
In the models using whole group data, we additionally
included a product term sex×diabetes status to test for
a potential interaction (effect modification) between
sex and diabetes status on cognitive function. We also
plotted the estimates of these models to visually inspect
for the possibility of an interaction. We further stratified the final model (including all potentially relevant
covariables) by diabetes status to explore within-strata
sex-cognition relationships. In the T1D and T2D groups
(separately), we additionally examined the effect of
including lifetime history of DKA and/or severe hypoglycemia on sex-cognition model associations. All analyses
were performed using SAS V.9.4.

Epidemiology/Health services research

n (%)
Demographics
 Age (years), mean (SD)

Whole group

Women

Men

1237

630 (51)

607 (49)

67.8 (6.6)

67.6 (6.5)

68.0 (6.7)

P value

0.23

 Race/Ethnicity, n (%)
  
White

1052 (85)

533 (85)

519 (86)

  
Hispanic

97 (8)

59 (9)

38 (6)

  
Asian

20 (2)

10 (2)

10 (2)

  African-American

21 (2)

10 (2)

11 (2)

  
Other

47 (4)

18 (3)

29 (5)

0.22

755 (61)

366 (58)

389 (64)

0.03

  
0–59 999

364 (29)

214 (36)

150 (26)

  
60 000–99 000

364 (29)

192 (32)

172 (30)

  100 000–199 000

342 (28)

151 (26)

191 (34)

89 (7)

35 (6)

54 (10)

  3rd grade or below

1 (0)

1 (0)

0 (0)

  
4th–6th grade

7 (1)

2 (0)

5 (1)

  
7th–8th grade

86 (7)

27 (4)

59 (10)

1143 (92)

600 (95)

543 (89)

0.001

538 (43)

262 (42)

276 (46)

0.19

  Do not drink, n (%)

322 (26)

165 (26)

157 (26)

  At least monthly, n (%)

421 (34)

234 (37)

187 (31)

  At least weekly, n (%)

481 (39)

226 (36)

255 (43)

 College degree, n (%)
 Annual household income (US$)

  
>200 000

<0.0001

 Health literacy, n (%)

  
High school
General health
 Every smoked >100 cigarettes, n (%)
 How often drink alcohol

 PSQI, mean (SD)
 GDS, mean (SD)

8.0 (2.7)
2.0 (2.3)

8.5 (2.8)
2.2 (2.4)

0.04

7.6 (2.6)

<0.0001

1.8 (2.1)

0.003

 No diabetes, n (%)

247 (20)

127 (20)

120 (20)

 Type 1 diabetes, n (%)

758 (61)

385 (61)

373 (61)

 Type 2 diabetes, n (%)

232 (19)

118 (19)

114 (19)

0.99

Diabetes characteristics
 Mean age at diabetes onset (years) (SD)

34.4 (18.4)

35.1 (19.0)

33.7 (17.9)

0.23

 Mean diabetes duration (years) (SD)

33.1 (17.8)

32.2 (18.0)

34.1 (17.5)

0.09

 Retinopathy, n (%)

341 (28)

183 (31)

158 (28)

0.30

 Neuropathy, n (%)

374 (30)

191 (31)

183 (32)

0.98

 Nephropathy, n (%)

61 (5)

29 (5)

32 (6)

0.49

 Stroke, n (%)

100 (8)

45 (7)

55 (9)

0.19

 Myocardial infarction, n (%)

126 (10)

54 (9)

72 (12)

0.05

 Severe hypoglycemia n (%)
 Diabetic ketoacidosis, n (%)

376 (30)
213 (17)

183 (29)
134 (21)

193 (32)
79 (13)

0.29
0.0006

Bold signifies p values≤0.05.
GDS, Geriatric Depression Scale; PSQI, Pittsburg Sleep Quality Index.
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Table 1 Sample characteristics stratified by sex
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T1D
n (%)
Demographics
 Age (years), mean (SD)

T2D

No diabetes

Women

Men

Women

Men

Women

Men

385 (51)

373 (49)

118 (51)

114 (49)

127 (51)
 

120 (49)
 

67.0 (6.2)

67.5 (6.4)

68.6 (7.0)

68.8 (7.1)

 Race/Ethnicity, n (%)

68.4 (6.8)

69.0 (7.2)

 

 

330 (86)

317 (85)

98 (83)

97 (85)

105 (83)

105 (88)

  
Hispanic

19 (5)

9 (2)

19 (16)

15 (13)

21 (17)

14 (12)

  
Asian

10 (3)

9 (2)

0 (0)

1 (1)

0 (0)

0 (0)

  African-American

10 (3)

11 (3)

0 (0)

0 (0)

0 (0)

0 (0)

White
  

  
Other

16 (4)

27 (7)

1 (1)

1 (1)

1 (1)

1 (1)

228 (59)

245 (66)

67 (57)

72 (63)

71 (56)

72 (60)

 

 

  
0–59 999

134 (35)

94 (25)

49 (42)

34 (30)

31 (24)

22 (18)

  
60 000–99 000

115 (30)

104 (28)

36 (31)

36 (32)

41 (32)

32 (27)

  100 000–199 000

88 (23)

115 (31)

23 (19)

29 (25)

40 (31)

47 (39)

  
>200 000

22 (6)

30 (8)

3 (3)

10 (9)

10 (8)

14 (12)

 

 

  3rd grade or below

0 (0)

0 (0)

0 (0)

0 (0)

1 (1)

0 (0)

  
4th–6th grade

1 (0)

3 (1)

1 (1)

1 (1)

0 (0)

1 (1)

 College degree, n (%)
 Annual household income (US$)

 Health literacy, n (%)

  
7th–8th grade
  
High school

14 (4)

29 (8)

10 (8)

13 (11)

3 (2)

17 (14)

370 (96)

341 (91)

107 (91)

100 (88)

123 (97)

102 (85)

 

 

157 (41)

159 (43)

57 (48)

62 (54)

48 (38)

55 (46)

 

 

General health
 Ever smoked >100 cigarettes, n (%)
 How often drink alcohol
  Do not drink, n (%)

104 (27)

109 (30)

41 (35)

31 (27)

20 (16)

17 (14)

  At least monthly, n (%)

134 (35)

96 (26)

50 (42)

47 (41)

50 (39)

44 (37)

  At least weekly, n (%)

143 (37)

161 (44)

26 (22)

35 (31)

57 (45)

59 (49)

 PSQI, mean (SD)

8.6 (2.9)

7.7 (2.6)

8.6 (2.4)

7.9 (2.7)

8.1 (2.7)

6.9 (2.1)

 GDS, mean (SD)

2.3 (2.5)

1.9 (2.1)

2.6 (2.7)

2.0 (2.2)

1.2 (1.4)

1.2 (1.5)

 Age at diabetes onset (years), mean (SD)

28.9 (16.4)

27.2 (13.7)

55.3 (11.2)

54.3 (13.4) N/A

N/A

 Diabetes duration (years), mean (SD)

38.0 (16.0)

40.3 (13.9)

13.4 (9.9)

14.5 (12.6) N/A

N/A

Diabetes characteristics

 

 

 Retinopathy, n (%)

175 (45)

145 (39)

7 (6)

12 (11)

1 (1)

1 (1)

 Neuropathy, n (%)

155 (40)

147 (39)

26 (22)

30 (26)

10 (8)

6 (5)

 Nephropathy, n (%)

28 (7)

31 (8)

0 (0)

1 (1)

1 (1)

0 (0)

 Stroke, n (%)

30 (8)

34 (9)

7 (6)

13 (11)

8 (6)

8 (7)

 Myocardial infarction, n (%)

44 (11)

50 (13)

6 (5)

16 (14)

4 (3)

6 (5)

 Severe hypoglycemia n (%)
 Diabetic ketoacidosis, n (%)

178 (46)
134 (35)

191 (51)
78 (21)

5 (4)
0 (0)

2 (2)
1 (1)

N/A
N/A

N/A
N/A

Bold signifies p values≤0.05.
GDS, Geriatric Depression Scale; N/A, not available; PSQI, Pittsburg Sleep Quality Index; T1D, type 1 diabetes; T2D, type 2 diabetes.

performance in global cognition (β=0.25, 95% CI 0.18
to 0.31), language (β=0.09, 95% CI −0.002 to 0.19), executive function (β=0.15, 95% CI 0.05 to 0.25), episodic
verbal memory (β=0.70, 95% CI 0.58 to 0.83) and attention than men (β=0.28, 95% CI 0.16 to 0.39) (all p≤0.05).
BMJ Open Diab Res Care 2021;9:e001646. doi:10.1136/bmjdrc-2020-001646

The addition of history of DKA to the fully adjusted
models in those with T1D resulted in the weakening of
the association of female sex with better language performance (β=0.09, 95% CI −0.008 to 0.18, p=0.07) but did
not meaningfully change the other reported associations.
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Table 2 Sample characteristics stratified by diabetes status
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Global
cognition

Executive
function

Episodic verbal Episodic visual
memory
memory

Attention

β (female sex) β (female sex)
(95% CI)
(95% CI)

β (female sex)
(95% CI)

β (female sex)
(95% CI)

β (female sex)
(95% CI)

β (female sex)
(95% CI)

Age+education

0.21
(0.16 to 0.26)

0.08
(0.004 to 0.15)

0.13
(0.05 to 0.20)

0.68
(0.59 to 0.77)

0.006
(−0.08 to 0.09)

0.20
(0.11 to 0.28)

Age+education+
diabetes status

0.21
(0.16 to 0.26)

0.08
(0.004 to 0.15)

0.13
(0.05 to 0.20)

0.68
(0.59 to 0.77)

0.006
(−0.07 to 0.09)

0.20
(0.11 to 0.28)

Sex×diabetes
interaction term (p) in above
model

0.34

0.92

0.83

0.21

0.88

0.12

Age+education+race

0.22
(0.17 to 0.26)

0.08
(0.01 to 0.15)

0.12
(0.05 to 0.20)

0.67
(0.58 to 0.77)

0.01
(−0.07 to 0.09)

0.20
(0.12 to 0.29)

Age+education+race+
diabetes status

0.22
(0.17 to 0.27)

0.08
(0.02 to 0.15)

0.13
(0.06 to 0.20)

0.68
(0.58 to 0.77)

0.007
(−0.07 to 0.09)

0.20
(0.12 to 0.29)

Sex×diabetes interaction
term (p) in above model

0.35

0.86

0.80

0.22

0.88

0.11

Age+education+race+PSQI+GDS 0.24
score
(0.18 to 0.29)

0.10
(0.03 to 0.17)

0.16
(0.08 to 0.23)

0.71
(0.61 to 0.80)

0.01
(−0.07 to 0.10)

0.23
(0.14 to 0.31)

Age+education+race+
0.24
PSQI+GDS score+diabetes status (0.18 to 0.29)

0.10
(0.03 to 0.17)

0.16
(0.08 to 0.23)

0.71
(0.61 to 0.81)

0.007
(−0.08 to 0.09)

0.22
(0.14 to 0.31)

Sex×diabetes interaction
term (p) in above model

0.90

0.92

0.52

0.79

0.28

0.05
(−0.03 to 0.12)

0.11
(0.04 to 0.18)

0.67
(0.58 to 0.77)

−0.01
(−0.10 to 0.07)

0.21
(0.12 to 0.30)

Model covariables

0.64

Age+education+race+PSQI+ GDS 0.20
score+diabetes
(0.15, 0.25)
status+neuropathy+nephropathy+
retinopathy+stroke+MI+health
literacy

Language

Diabetes status stratification
 Type 1 diabetes*

0.25
(0.18 to 0.31)

0.09
0.15
(−0.002 to 0.19) (0.05 to 0.25)

0.70
(0.58 to 0.83)

0.01
(−0.10 to 0.13)

0.28
(0.16 to 0.39)

 Type 2 diabetes*

0.19
(0.07 to 0.31)

0.13
(−0.03 to 0.30)

0.13
(−0.03 to 0.29)

0.65
(0.42 to 0.87)

−0.05
(−0.21 to 0.11)

0.15
(−0.07 to 0.37)

 No diabetes*

0.24
(0.13 to 0.35)

0.08
(−0.07 to 0.24)

0.19
(0.04 to 0.35)

0.79
(0.59 to 1.00)

0.05
(−0.14 to 0.24)

0.14
(−0.05 to 0.33)

Bold signifies p values≤0.05.
*Models adjusted for age, education, race, PSQI score and GDS score.
GDS, Geriatric Depression Scale; MI, myocardial infarction; PSQI, Pittsburg Sleep Quality Index.

The further addition of history of severe hypoglycemia
requiring hospitalization did not result in any further
meaningful change in the reported associations. In those
with T2D, women had better cognitive performance than
men in global cognition (β=0.19, 95% CI 0.07 to 0.31)
and episodic verbal memory (β=0.65, 95% CI 0.42 to
0.87) (all p≤0.001) but not the other cognitive domains.
The inclusion of history of DKA and/or severe hypoglycemia did not meaningfully change our results. In those
without diabetes, female sex was associated with better
global cognition (β=0.24, 95% CI 0.13 to 0.35), executive function (β=0.19, 95% CI 0.04 to 0.35) and episodic
verbal memory (β=0.79, 95% CI 0.59 to 1.00) than men
(all p<0.01). There were no associations between sex and
language, episodic visual memory or attention factors
among individuals without T1D or T2D. Figure 1 provides
a visual representation of the associations between sex
and predicted cognitive domain factor scores within
diabetes status strata using the models described in
6

table 3. The unadjusted mean cognitive factor scores by
sex and diabetes status are presented in online supplemental table 2. The inclusion of measures of cardiovascular health and health literacy resulted in minimal
attenuation of the associations between female sex and
the cognitive outcomes (data not shown), with the only
meaningful change being the previously described association between female sex and greater executive function in those without diabetes was no longer statistically
significant (β=0.11, 95% CI −0.04 to 0.26).
DISCUSSION
In this sample of people without dementia, we found
that women performed better than men globally and
in many of the individual cognitive domains regardless
of diabetes status. Furthermore, the amplitude of the
sex differences appeared similar across diabetes states.
To our knowledge, previous studies have not examined
BMJ Open Diab Res Care 2021;9:e001646. doi:10.1136/bmjdrc-2020-001646
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Table 3 Multiple linear regression models of sex and cognitive domains in the whole group and stratified by diabetes status*
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for the presence of sex differences in cognitive function across T1D and T2D. These results suggest that the
well-
described better cognitive functioning of women
compared with men without dementia is maintained in
the presence of both T1D and T2D.
Previous work has reported that in people without
diabetes, women have better cognitive functioning
than men. Both the original analyses of the Health and
Retirement Study21 and the follow-up of the same study
performing a modified version of the Telephone Interview for Cognitive Status on 18 982 people aged 51 years
or older, reported that women had better global cognition
and cognitive subdomains scores than men.22 A similar
pattern was observed in a study of 2503 participants in the
Framingham Heart Study where women (mean age >60
years) had significantly higher performance on visual/
spatial memory, verbal memory and attention/concentration than men.23 Reconciling this observation with the
greater dementia risk in women has led others to suggest
that better cognitive test performance of women may
mask functional cognitive changes leading to delayed
diagnosis and at more advanced stages.3
Fewer studies have examined the role of sex differences
on cognitive outcomes in people with diabetes.8 24–30
Research on cognitive outcomes in older people with
T1D have started only recently, partly due to the relatively recent ability of people with T1D to reach older
ages. In those studies that have examined the associations
between sex and cognition, specific sex difference data
have not been presented.
Studies of sex differences in cognition in people with
T2D have mostly focused on dementia as the outcome
of interest. A 2016 meta-analysis of 2.3 million people
reported that women with T2D had a greater risk of
dementia than men with T2D.8 When examined by
dementia subtype, women had a greater risk than men
only for vascular dementia. The results from the Action for
Health in Diabetes, a randomized controlled clinical trial
BMJ Open Diab Res Care 2021;9:e001646. doi:10.1136/bmjdrc-2020-001646

of a 10-year intensive lifestyle intervention in people aged
45–76 years with T2D reported that women (n=2323) had
a 30% lower prevalence of mild cognitive impairment
(MCI; a precursor to dementia) and better cognitive
performance at study completion than men (n=1479).31
The authors reported that these sex differences were
not attributable to other risk factor profile characteristics, T2D treatment or glycemic control differences. Our
observation that between-sex differences in cognition was
similar in all three groups and that the better cognitive
performance in women was independent of occurrence
of DKA lends credence to the argument that differences
in glycemic control or diabetes treatments do not seem to
explain the between-sex cognitive differences we report.
More detailed work is required to better understand the
role of more nuanced measures of glycemic control in sex
differences and cognitive outcomes, which are lacking in
our study.
Previous work has reported that men tend to perform
better than women in visual memory tasks.12 However, in
our sample, we found that men and women had similar
visual memory ability. The implications of this are unclear.
Further work, including the use of sensitive neuroimaging biomarkers of function and structure would help
explore the significance of this finding.
The biological or mechanistic factors underlying the
generally better cognitive function in women than men
remain unclear. Sex hormones are known to be neuroprotective in both sexes13 and the results of some studies
suggest that women’s hormonal profile may explain some
of the cognitive differences seen. Women with estrogen
deficiency (induced either by surgical or hormone antagonism) show a reduction in verbal memory that is reversible with estrogen treatment or resumption of normal
ovarian function.14 15 However, it is unknown whether,
or how, hormonal changes might be related to function
in a particular cognitive domain. Work performed in the
Alzheimer’s Disease Neuroimaging Dataset suggests that
7
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Figure 1 Associations between sex and predicted cognitive performance by diabetes status*. *Adjusted for age, race/
ethnicity, education, Pittsburg Sleep Quality Index score and Geriatric Depression Scale score. Models based on a white
person aged 70 years with a college degree. DM, diabetes mellitus; T1D, type 1 diabetes; T2D, type 2 diabetes.
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greater than expected age at diagnosis of those with T1D
might be reflective of the biases of healthier people to
enroll in studies or be the result of survivor-bias, whereby
those with earlier age of diagnosis may not have survived
to the age to be eligible to be included in our study. It is
also possible that cognitive changes in our cohort were
too subtle to detect with our neuropsychological tests.
Future plans include obtaining objective measures of
health from the medical record and following enrolled
participants longitudinally for cognitive change. As we
currently present cross-sectional analyses, it is important
to understand whether these patterns continue over time
or whether there are between-sex differences in cognitive
trajectories.
In summary, women in mid-later life have better cognitive performance than men in many cognitive domains
and this is independent of the presence of T1D or T2D.
Further work is required to understand whether these
differences change over time and their relationship to
subsequent dementia.
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these sex-cognitive domain differences are preserved even
in the presence of disease, with women with amnestic MCI
displaying better verbal memory than men with MCI.32
Furthermore, the authors reported that these differences
remained apparent even though hippocampal volume
(important in verbal memory) was similar. These results
suggest that there may be important between-sex differences in brain structure that might explain difference
in cognitive function. Although no consistent patterns
of sex-
related brain structural differences have been
found,33–46 differences in number and density of neurons
as well as brain size may all be important in understanding
sex-related patterns in specific cognitive domains as well
as sex differences in future dementia risk.47 48
We found that the associations between sex and cognitive function were independent of the known associations between diabetes and cognition. Similarly, the
associations between diabetes and cognitive function
did not vary by sex. Although our study suggests that
the cognitive action of these two important risk factors
are independent of each other, it is important to recognize the possibility that factors associated with sex and
diabetes may still interact in ways we did not detect. The
pathways through which both diabetes and female sex
lead to increased risk of dementia remain unknown.
Additional research is needed to examine the protective
role of female hormones on vascular risk factors and the
implications of menopause on this loss of protection and
long-term brain health.
This study has a number of strengths including the
large sample size of people with T1D, inclusion of well-
matched T2D and without diabetes samples, and the use
of detailed comprehensive cognitive tests allowing for
investigation of the effects of sex on specific cognitive
domains. This study also has some limitations. We lacked
comprehensive detail of other factors of interest such as
severity of comorbidities, biomarkers of glucose control
and anthropometry such as body mass index. On visualization of the data, if any sex-diabetes class interactions
are present, they appear to be very subtle and would
require much larger sample sizes. Previous work in large
meta-analyses has reported that in people with diabetes,
women have a greater risk of stroke10 and coronary heart
disease11 than men. We did not see this pattern in our
cohort. It is likely that volunteer study participants are
healthier than their non-volunteering counterparts. This
is particularly the case when recruiting older people with
T1D, who are likely to have had better glycemic control
and fewer health complications throughout life than
their counterparts who have since died, which may lead
to survivor bias. We found a similar pattern within our
sample, whereby those who completed all the cognitive tests appeared healthier with greater education
and annual household income that those who did not
complete all cognitive tests. It is possible that the associations we report would be different in those who had
poorer glycemic control, greater burden of diabetes-
related or non-
diabetes-
related comorbidities. The
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Supplementary Table 1. Sample characteristics of those who completed and did not
Whole group
n (%)
Demographics
Age (years) Mean (SD)
Race/ethnicity, n (%)

1237
67.8 (6.6)
White 1052 (85)

Missing global
cognition
70
70.4 (7.2)
60 (85)

complete all cognitive tests.
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Hispanic
Asian
African American
Other

97 (8)
20 (2)
21 (2)
47 (4)
755 (61)

5 (7)
1 (1)
1 (1)
3 (4)
37 (53%)

$USD 0-59,999
$USD 60,000-99,000
$USD 100,000-199,000
>$USD 200,000

364 (29)
364 (29)
342 (28)
89 (7)

31 (44)
8 (11)
19 (27)
3 (4)

538 (43)

32 (46)

College degree, n (%)
Annual household income

General health
Every smoked> 100 cigarettes, n (%)
How often drink alcohol

Don’t drink, n (%) 322 (26)
At least monthly, n (%) 421 (34)
At least weekly, n (%) 481 (39)
PSQI, Mean (SD)
8.0 (2.7)
GDS, Mean (SD)
2.0 (2.3)
Subjective memory loss, n (%)
720 (58)
No Diabetes, n (%)
247 (20)
Type 1 Diabetes, n (%)
758 (61)
Type 2 Diabetes, n (%)
232 (19)
Diabetes characteristics
Mean age at diabetes onset (years)(SD)
34.4 (18.4)
Mean diabetes duration (years) (SD)
33.1 (17.8)
Retinopathy, n (%)
341 (28)
Neuropathy, n (%)
374 (30)
Nephropathy, n (%)
61 (5)
Stroke, n (%)
100 (8)
Myocardial infarction, n (%)
126 (10)
Severe hypoglycemia n (%)
376 (30)
Diabetic ketoacidosis, n (%)
213 (17)

25 (36)
21 (30)
21 (30)
8.6 (3.2)
3.5 (3.7)
41 (59)
11 (16)
43 (61)
16 (23)
30.9 (16.8)
38.8 (16.7)
23 (33)
30 (43)
7 (10)
11 (16)
10 (14)
26 (37)
16 (23)
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Supplementary Table 2. Raw mean cognitive function factor scores by sex and diabetes
status

Type 1 diabetes, n (%)
Global score
Language
Executive
Verbal episodic memory
Visual episodic memory
Attention

n
758
743
745
370
377

Type 2 diabetes, n (%)
Global score
Language
Executive
Verbal episodic memory
Visual episodic memory
Attention

118
117
117
110
116
117

Global score
Language
Executive
Verbal episodic memory
Visual episodic memory
Attention

247
244
246
237
242
246

No Diabetes, n (%)

Women
Factor Score
(Mean (SD))
409 (51)
0.14 (0.51)
0.04 (0.69)
0.05 (0.77)
0.33 (0.84)
0.14 (0.77)
0.16 (0.64)
125 (50.4)
0.06 (0.48)
0.08 (0.73)
0.13 (0.70)
0.37 (0.81)
-0.26 (0.60)
0.0002 (0.78)
127
0.22 (0.53)
0.22 (0.73)
0.35 (0.75)
0.48 (0.78)
-0.02 (0.72)
0.12 (0.72)

Men
Factor Score
(Mean (SD))
396 (49)
-0.09 (0.50)
-0.02 (0.67)
-0.09 (0.76)
-0.36 (0.90)
0.13 (0.76)
-0.11 (0.82)
123 (49.6)
-0.07 (0.50)
0.02 (0.67)
0.07 (0.63)
-0.15 (0.87)
-0.22 (0.64)
-0.07 (0.84)
120
-0.005 (0.52)
0.11 (0.68)
0.19 (0.68)
-0.31 (0.89)
-0.05 (0.80)
0.01 (0.73)
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